These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39338397)

  • 21. Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.
    Chiquet C; Dupuy C; Bron AM; Aptel F; Straub M; Isaico R; Romanet JP; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2095-102. PubMed ID: 25673251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcomes of Patients With Active Diabetic Macular Edema at the Time of Cataract Surgery Managed With Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Starr MR; Mahr MA; Smith WM; Iezzi R; Barkmeier AJ; Bakri SJ
    Am J Ophthalmol; 2021 Sep; 229():194-199. PubMed ID: 33852907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study.
    Ruiz-Moreno JM; Ruiz-Medrano J
    Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):941-949. PubMed ID: 36370170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes.
    Neves P; Ornelas M; Matias I; Rodrigues J; Santos M; Dutra-Medeiros M; Martins D
    Int J Ophthalmol; 2021; 14(10):1571-1580. PubMed ID: 34667735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
    Ozsaygili C; Duru N
    Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cataract surgery with combined versus deferred intravitreal dexamethasone implant for diabetic macular edema: long-term outcomes from a real-world setting.
    Corbelli E; Fasce F; Iuliano L; Sacconi R; Lattanzio R; Bandello F; Querques G
    Acta Diabetol; 2020 Oct; 57(10):1193-1201. PubMed ID: 32367246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal Dexamethasone Implant in Patients Who Did Not Complete Anti-VEGF Loading Dose During the COVID-19 Pandemic: a Retrospective Observational Study.
    Scorcia V; Giannaccare G; Gatti V; Vaccaro S; Piccoli G; Villì A; Toro MD; Yu AC; Iovino C; Simonelli F; Carnevali A
    Ophthalmol Ther; 2021 Dec; 10(4):1015-1024. PubMed ID: 34482532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal Dexamethasone Implant Has Better Retinal Perfusion than Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion: A Five-Year Real-World Study.
    Zhang M; Liu Y; Song M; Yu Y; Ruan S; Zheng K; Wang F; Sun X
    Ophthalmic Res; 2023; 66(1):247-258. PubMed ID: 36215955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes of Taiwanese patients with treatment-naïve diabetic macular edema.
    Wang JK; Huang TL; Chang PY
    J Formos Med Assoc; 2020 Nov; 119(11):1619-1625. PubMed ID: 32482606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
    Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
    Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand.
    Pietzuch M; Mantel I; Ambresin A; Tappeiner C; Nagyova D; Donati G; Pfister IB; Schild C; Garweg JG
    J Ocul Pharmacol Ther; 2024; 40(6):361-369. PubMed ID: 38117666
    [No Abstract]   [Full Text] [Related]  

  • 35. Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery.
    Lai CC; Kuo SC
    BMC Ophthalmol; 2023 Aug; 23(1):352. PubMed ID: 37559002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intravitreal dexamethasone implant and anti-VEGF drugs in the treatment of retinal vein occlusion-induced oedema: a meta-analysis and systematic review.
    Ming S; Xie K; Yang M; He H; Li Y; Lei B
    BMJ Open; 2020 Jun; 10(6):e032128. PubMed ID: 32595145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-Life Management of Diabetic Macular Edema with Dexamethasone Intravitreal Implant: A Retrospective Analysis of Long-Term Clinical Outcomes.
    Nicolò M; Musetti D; Marenco M; Cotti L; Bonetto M; Giacomini M; Traverso CE
    J Ophthalmol; 2020; 2020():4860743. PubMed ID: 32351722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF.
    Starr MR; Mahr MA; Iezzi R; Barkmeier AJ; Bakri SJ
    Semin Ophthalmol; 2020 May; 35(4):205-209. PubMed ID: 32721186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India.
    Chakraborty D; Mondal S; Sengupta S; Maiti A; Boral S; Das A; Sinha TK; Nandi K
    Indian J Ophthalmol; 2024 Jul; 72(7):1001-1006. PubMed ID: 38622856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.